Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antibiotics
100%
Randomized Clinical Trial
100%
Outpatient Parenteral Antibiotic Therapy
100%
Community-acquired Pneumonia
100%
Scouting
100%
Community-acquired Pneumonia in children
100%
Short Course
80%
Antibiotic Duration
80%
Adverse Effects
60%
Clinical Response
60%
Antibiotic Risks
60%
Prokaryotic Cells
60%
Desirability of Outcome Ranking
60%
Antibiotic Resistance
40%
Hispanic or Latino
40%
Resistance Genes
40%
Antibiotic Resistance Genes
40%
Placebo
20%
Initial Treatment
20%
Clinical Improvement
20%
Healthy children
20%
Randomized Placebo-controlled Trial
20%
Trial Registration
20%
Treatment Strategy
20%
Young children
20%
Risk Outcomes
20%
β-lactamase
20%
Healthcare Settings
20%
Symptom Resolution
20%
Emergency Setting
20%
Antibiotic Treatment
20%
Outpatient Clinic
20%
Median Range
20%
Antibiotic Exposure
20%
End of Treatment
20%
Composite Endpoint
20%
Non-severe
20%
Black or African American
20%
US Cities
20%
Throat Swab
20%
Nasopharyngeal Microbiota
20%
Urgent Care
20%
Antibiotic Strategies
20%
Resistome Analysis
20%
Total Resistance
20%
Medicine and Dentistry
Outpatient
100%
Antibiotic Therapy
100%
Community-Acquired Pneumonia
100%
Randomized Clinical Trials
100%
Antibiotic Resistance
50%
Adverse Effect
50%
Prokaryotic Cell
50%
Placebo
33%
Treatment Response
16%
Penicillinase
16%
Controlled Clinical Trial
16%
Urgent Care
16%
Throat Culture
16%
Antibiotics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Antibiotic Therapy
100%
Community Acquired Pneumonia
100%
Antibiotic Resistance
50%
Placebo
33%
Antibiotics
16%
Penicillinase
16%
Controlled Clinical Trial
16%